Richard M. Silver

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al. · Arthritis & Rheumatism · 2013 · 3.4K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al. · Annals of the Rheumatic Diseases · 2013 · 2.9K citations

Medicine, Clinical Sciences, Internal Medicine +15

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +11

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Otylia Kowal‐Bielecka, Robert Landewé, Jérôme Avouac et al. · Annals of the Rheumatic Diseases · 2009 · 617 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11